ArticleThe Biochemical journal2025
Involvement of hcp2 on maintaining cell wall integrity and pathogenicity of Vibrio alginolyticus by modulating Sec pathway.
Article in The Biochemical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Hemolysin co-regulated protein 2 (Hcp2) is a core component of the type VI secretion system 2 in Vibrio alginolyticus, a widespread marine pathogen that infects humans and aquaculture species. Deletion of hcp2 (Δhcp2) significantly attenuated virulence in zebrafish larvae, showing reduced abdominal edema and impaired toll-like receptor (tlr)2 and tlr4-mediated innate immune activation compared with the wildtype strain. Enzyme-linked immunosorbent assay and cell lysis assays revealed that the Δhcp2 strain exhibited decreased levels of lipopolysaccharide (LPS) and peptidoglycan (PGN), along with increased cell permeability and abnormal cell wall structures observed by transmission electron microscopy. Proteomic and transcriptional analyses further demonstrated that expression of the Sec system components SecB, SecD, and SecF was markedly reduced in the Δhcp2 strain and positively regulated by hcp2. Bioinformatic prediction combined with protein-DNA docking analysis suggested that the transcription of secB, secD, and secF was co-regulated by the cAMP and cAMP Receptor Protein (cAMP-CRP) complex and RNA polymerase sigma D factor (RpoD), although rpoD expression itself remained unaffected. Together with previous evidence that Hcp2 positively regulates cAMP-CRP, these findings suggested that Hcp2 modulated LPS and PGN translocation, probably through the cAMP-CRP pathway, thereby maintaining cell wall integrity and virulence in V.alginolyticus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.